nivolumab,rigosertib
onconova therapeutics,SymBio pharmaceuticals,Knight Therapeutics,bms
['rigoser', 'nivo', 'lung', 'nivolumab', 'onconova therapeutics', '$ontx']
$ontx onconova therapeutics therapeutics announces updated data from investigator-sponsored phase 1/2a trial evaluating rigosertib in combination with nivolumab in advanced kras-mutated non-small cell lung cancer at the esmo congress 2022 
GetOnTrade is a news platform to help you stay up-to-date with the latest stock market news. We are not financial advisor(please do your own due diligence).